Reversal of Obesity and Insulin Resistance by a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist in Diet-Induced Obese Mice

BACKGROUND: Glucagon-like peptide-1 (GLP-1) is recognized as an important regulator of glucose homeostasis. Efforts to utilize GLP-1 mimetics in the treatment of diabetes have yielded clinical benefits. A major hurdle for an effective oral therapy has been the difficulty of finding a non-peptidic GL...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Min, Su, Haoran, Gao, Weiwei, Johansson, Stina M., Liu, Qing, Wu, Xiaoyan, Liao, Jiayu, Young, Andrew A., Bartfai, Tamas, Wang, Ming-Wei
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997064/
https://www.ncbi.nlm.nih.gov/pubmed/21151924
http://dx.doi.org/10.1371/journal.pone.0014205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997064/
https://www.ncbi.nlm.nih.gov/pubmed/21151924
http://dx.doi.org/10.1371/journal.pone.0014205

Ejemplares similares